Total Voting Rights
Oxford Biomedica PLC has announced its total voting rights as of 30 April 2026, stating that its issued share capital consists of 120,920,518 ordinary shares of 50 pence each, with no shares held in treasury. This figure of 120,920,518 represents the total number of voting rights available to shareholders for notification purposes under the FCA's Disclosure Guidance and Transparency Rules.
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK - 01 May 2026: OXB (LSE: OXB) (the "Company"), a global quality and innovation-led cell and gene therapy CDMO, today announces that in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, the Company's issued share capital as at the close of business on 30 April 2026 consisted of 120,920,518 ordinary shares of 50 pence each ("Ordinary Shares"). There are no Ordinary Shares held in treasury.
Accordingly, the total number of voting rights in OXB at the date of this notice is 120,920,518.
The above figure 120,920,518 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, OXB under the FCA's Disclosure Guidance and Transparency Rules.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.